European Commission Approves TREVICTA® (paliperidone palmitate a 3-monthly injection), for Maintenance Treatment of Schizophrenia
- EMEA Innovative Medicine
- European Commission Approves TREVICTA® (paliperidone palmitate a 3-monthly injection), for Maintenance Treatment of Schizophrenia
European Commission Approves TREVICTA® (paliperidone palmitate a 3-monthly injection), for Maintenance Treatment of Schizophrenia
- X (Twitter)
Copy link